发明人郑宇鹏,沈红梅,徐明华. "Method for the Synthesis of Methyl 1-((2-chlorothiazol-5-yl)methyl)-1H-indole-2-carboxylate" [P]. 中国发明专利, 专利号 CN 112193071 A, 授权公告日 2016-09-21.
发明人王建平,韩伟,黄志刚. "A Process for Preparing High-Purity Methyl 1-((2-chlorothiazol-5-yl)methyl)-1H-indole-2-carboxylate" [P]. 中国发明专利, 专利号 CN 113290755 B, 授权公告日 2021-09-21.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2016, 1596, (11), 4370-4397.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2020, 1519, 2118-2140.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 1-((2-chlorothiazol-5-yl)methyl)-1H-indole-2-carboxylate Using HRMS and NMR". Anal. Methods, 2016, 367, (5), 9941-9962.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2019, 929, 675-701.